Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 – 2017)

Publisher Name :
Date:18-Jan-2013
No. of pages: 896
Inquire Before Buying

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, epigenetics offers a potential opportunity in understanding the basis of various diseases in a different approach. Thus, epigenetics is study of heritable changes in genome function and gene expression had opened the new gate of biology to understand the basis of diseases and presents incredible opportunities for disease diagnosis and drug discovery.

Report covers the market by therapeutics sector in oncology conditions, non-oncology indications and personalized medicine. The report also covers the market by research and diagnostics sector in gene regulation studies, biomarker detection and drug discovery. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Epigenetics market is showing a double digit growth (CAGR 25%) due to supportive factors such as, (i) huge amount of funds and investments, (ii) increasing partnerships and collaborations, and (iii) rapid screening tools. Epigenetics is used in the identification of new epigenetic biomarkers, which will aid in better diagnosis and prognosis of diseases. While there are factors favoring the market growth, there are concerns such as change in re-imbursement systems and lack of predictive markers holding back the growth of this market. However, the positive aspects in this field may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: CH3 BioSystems (U.S.), Eisai (Japan), Covaris Inc. (U.S.), Epiontis (Germany), RiboMed Biotechnologies (U.S.), 4SC (Germany), Novus Biologicals (U.S.), Merck Millipore (U.S.), CellCentric (U.K.), Celgene (U.S.), Karus Therapeutics (U.K.), EpiTherapeutics (Denmark), Resverlogix (Canada), Epizyme (U.S.), Glaxosmithkline (U.K.), Epigenomics (Germany).

Scope of the Report

  • This technology report categorizes the market for epigenetics by geographical region (including the important countries in each region), applications, and epigenetic mechanisms, forecasting the market value in revenue by analyzing the current and future trends in research, diagnostics and therapeutics industries.
  • A detailed description of the global technology developments and evolving trends in the epigenetics field with key prominence on research innovations, collaborative efforts and focused research through consortiums dedicated for epigenetics.
  • A close view on the drug development for treatment of various diseases by providing the details and status of current epigenetic drugs in pipeline.
  • An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of epigenetics market during the period from 2012 to 2017.
  • Market size – Global market forecast for 2012-2017, including demand side analysis and strategic recommendations for technology/product developers.
  • Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.

Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 – 2017)

Table of Contents

1 Introduction
1.1 Key Take-Aways
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data Points From Primary And Secondary Sources

2 Executive Summary

3 Epigenetics – Technology Landscape Analysis
3.1 Technology Overview
3.2 Technology Evolution – Milestones In Epigenetics
3.3 Epigenetic Mechanisms
3.3.1 DNA Methylation
3.3.2 Histone Modifications
3.3.3 RNA Interference
3.4 Technology Value Chain Analysis
3.5 Applications
3.5.1 Therapeutics
3.5.1.1 Oncology Conditions
3.5.1.2 Non-Oncology Indications
3.5.1.3 Personalized Medicine
3.5.2 Research And Diagnostics
3.5.2.1 Gene Regulation Studies
3.5.2.2 Biomarker Detection
3.5.2.3 Drug Discovery
3.6 Epigenetics – Technology Innovations And Products With Applications
3.7 Current Scenario In Epigenetics

4 Epigenetics – Market Landscape Analysis
4.1 Epigenetics Market Size – Potential Addressable Market
4.2 Global Epigenetics Market Segmentation
4.3 Global Market Revenue Forecast (2012-2017)
4.3.1 By Geography
4.3.2 By Applications
4.3.3 By Epigenetic Mechanisms
4.4 Market Share of Companies
4.5 Market Dynamics
4.5.1 Drivers
4.5.2 Restraints
4.5.3 Challenges

5 Technology Investment Potential
5.1 Investor Network
5.1.1 Some Funds And Investments By Public Funding Bodies
5.1.2 Some Funds And Investments By Non-Government Organizations (Ngos)
5.1.3 Some Investments By Corporate, Private And Equity Investors
5.1.4 Insights on Current And Future Tech-Investment Trends
5.1.5 Funding Patterns And Investor Inclination
5.2 Investment Opportunities
5.2.1 Epigenetic Technologies And Products Available For Licensing & Acquisition For Stakeholders
5.2.2 Analysis of Potential Application Areas For Technology Investment – Based On Opportunity Strategy Evaluation (OSE) Analysis

6 Epigenetics – Technology Adoption Potential And Development By Geography
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia
6.5 Row
6.6 Demand Side Analysis

7 Epigenetics Competitive Landscape
7.1 Key Mergers And Acquisitions
7.2 Partnerships And Collaborations
7.3 Therapeutic Drugs In Pipeline
7.4 Worldwide Consortiums And Networks In Epigenetics

8 Intellectual Property And Research Strength Analysis
8.1 Ip Strength Analysis of Epigenetics Between 2008-2012
8.2 Analysis of Research Strength From Ncbi Pubmed Publications

9 Analyst Insights And Recommendations
9.1 Analyst Insights
9.2 Analyst Recommendations
9.3 Open Opportunity Invitations In The Field For Business Development

10 Company Profiles
10.1 4sc (Germany)
10.2 Celgene (U.S.)
10.3 Cellcentric (U.K.)
10.4 Ch3 Biosystems (U.S.)
10.5 Covaris Inc (U.S.)
10.6 Eisai Co Ltd (Japan)
10.7 Epiontis (Germany)
10.8 Epitherapeutics (Denmark)
10.9 Epizyme (U.S.)
10.10 Karus Therapeutics (U.K.)
10.11 Merck Millipore (U.S.)
10.12 Ribomed Biotechnologies (U.S.)

11 Appendix

12 Glossary

List of Tables

Table 1 Global Epigenetics Market Revenue, By Geography, 2012–2017 ($Million)
Table 2 Global Epigenetics Market Revenue, By Application Segments, 2012–2017 ($Million)
Table 3 Global Epigenetics Market Revenue, By Therapeutic Applications, 2012–2017 ($Million)
Table 4 Global Epigenetics Market Revenue, By Research & Diagnostics Applications, 2012–2017 ($Million)
Table 5 Global Epigenetics Market Revenue, By Epigenetic Mechanisms, 2012–2017 ($Million)
Table 6 Market Share of Companies Based On Currently Available Four Drugs
Table 7 Some Funds And Investments By Public Funding Bodies
Table 8 Epidemiology And Genomics Research Program (Egrp) Funding Details For Epigenetics
Table 9 Nih Funding Details For Epigenetics
Table 10 Some Funds And Investments By Non-Government Organizations (Ngos)
Table 11 Some Investments By Corporate, Private And Equity Investors
Table 12 Worldwide Incidence & Mortality of Selected Cancers (Cases/Year)
Table 13 Mergers And Acquisitions
Table 14 Partnerships And Collaborations
Table 15 Therapeutic Drugs In Pipeline
Table 16 Key Patents
Table 17 Different Types of Products For Epigenetic Mechanisms – Dna Methylation
Table 18 Different Types of Products For Epigenetic Mechanisms – Histone Modifications
Table 19 Different Types of Products For Epigenetic Mechanisms – Rna Interference

List of Figures

Fig 1 Global Market of Epigenetics 2012–2017 ($Million)
Fig 2 Global Epigenetics Market Revenue, By Geography, 2012–2017 ($Million)
Fig 3 Global Epigenetics Market Share – By Geography
Fig 4 Global Epigenetics Market Revenue, By Application Segments,2012-2017 ($Million)
Fig 5 Global Epigenetics Market Revenue, By Therapeutic Applications, 2012–2017 ($Million)
Fig 6 Global Epigenetics Market Revenue, By Research & Diagnostics Applications, 2012–2017 ($Million)
Fig 7 Global Epigenetics Market Share – By Applications
Fig 8 Global Epigenetics Market Revenue, By Epigenetic Mechanisms, 2012–2017 ($Million)
Fig 9 Market Share of Companies Based on Currently Available Four Drugs
Fig 10 Epidemiology And Genomics Research Program (Egrp) Funding Details For Epigenetics
Fig 11 Nih Funding Details For Epigenetics
Fig 12 Epigenetics, Year-Wise Funding Patterns & Investment Forecast (2012–2017)
Fig 13 Current FundingPattern By Investors For Epigenetics
Fig 14 Patents Published Between 2008-2012
Fig 15 Pubmed Publications Between 2008-2012
Fig 16 Pubmed Publications on Epigenetic Enzymes 2008-2012

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) – Global Forecast to 2018
    Published: 14-Aug-2014        Price: US $4650 Onwards        Pages: 220
    The applications of whole exome sequencing (WES) technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems as well as the low cost of conducting exome sequencing, as compared with that of whole genome sequencing. The technological advancement is evident from the number of improved versions of existing sequencers released in recent years. For instance, in January 2014, the leading player in the whole exome sequencing market, Illu......
  • Avaxia Biologics, Inc. – Product Pipeline Review – 2014
    Published: 14-Aug-2014        Price: US $1500 Onwards        Pages: 23
    Global Markets Direct's, ‘Avaxia Biologics, Inc. Product Pipeline Review 2014', provides an overview of the Avaxia Biologics, Inc.'s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Avaxia Biologics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews late......
  • Lycera Corp. – Product Pipeline Review – 2014
    Published: 14-Aug-2014        Price: US $1500 Onwards        Pages: 22
    Global Markets Direct's, ‘Lycera Corp. Product Pipeline Review 2014', provides an overview of the Lycera Corp.'s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Lycera Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news ......
  • Biotecnol, Inc. – Product Pipeline Review – 2014
    Published: 14-Aug-2014        Price: US $1500 Onwards        Pages: 22
    Global Markets Direct's, ‘Biotecnol, Inc. Product Pipeline Review 2014', provides an overview of the Biotecnol, Inc.'s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Biotecnol, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featu......
  • 2014 Deep Research Report on Global and China Docosahexaenoic Acid (DHA) Industry
    Published: 6-Aug-2014        Price: US $2200 Onwards        Pages: 177
    This is a professional and depth research report on Global and China Docosahexaenoic Acid (DHA) industry. The report firstly introduced Docosahexaenoic Acid (DHA) basic information included Docosahexaenoic Acid (DHA) definition Docosahexaenoic Acid (DHA)ssification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Docosahexaenoic Acid (DHA) industry policy......
  • 2014 Deep Research Report on Global and China Papain Industry
    Published: 5-Aug-2014        Price: US $2200 Onwards        Pages: 155
    This is a professional and depth research report on Global and China Papain industry. The report firstly introduced Papain basic information included Papain definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Papain industry policy and plan, Papain product specification, manufacturing process, cost structure etc. then statistics Global and China ......
  • Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) – Global Forecast to 2018
    Published: 5-Aug-2014        Price: US $4650 Onwards        Pages: 265
    The global molecular biology enzymes, kits and reagents market is segmented by application, end users, products, and geographies. Molecular biology enzymes, kits and reagents find applications in a large number of fields of life science research. The application segments included in this report are cloning, epigenetics, PCR (polymerase chain reaction), restriction digestion, sequencing, and other applications. The end-user segments of this market are academic research institutes, hospitals and d......
  • Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) – End-User Analysis & Global Forecast to 2018
    Published: 4-Aug-2014        Price: US $4650 Onwards        Pages: 201
    Western Blotting Market –[By Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), By Application (Disease Diagnosis/Agriculture/Biomedical Research)]-End-User Analysis & Global Forecast to 2018Over the years, the western blotting market, comprising of instruments and consumables, has witnessed various technological advancements to improve the sensitivity, reproducibility, quantifiability, and speed of western blot experiments. These advancements......
  • Market Research Report on Global and Chinese Purine nucleoside phosphorylase (PNP) (CAS 9030-21-1) Industry, 2009-2019
    Published: 3-Aug-2014        Price: US $2400 Onwards        Pages: 150
    Market Research Report on Global and Chinese Purine nucleoside phosphorylase (PNP) Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Purine nucleoside phosphorylase (PNP) industry. The report firstly reviews the basic information of Purine nucleoside phosphorylase (PNP) including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Purine nucleoside phosphorylase (PNP) listing their......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs